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A B S T R A C T
Exposure to ambient particulate matter (PM) has been associated with the onset of neurodevelopmental
and neurodegenerative disorders, but the mechanism of toxicity remains unclear. To gain insight into this
neurotoxicity, this study sought to examine global gene expression changes caused by exposure to
ambient ultrafine PM. Microarray analysis was performed on primary human neurons derived from fetal
brain tissue after a 24 h exposure to 20 mg/mL of ambient ultrafine particles. We found a majority of the
changes in noncoding RNAs, which are involved in epigenetic regulation of gene expression, and thereby
could impact the expression of several other protein coding gene targets. Although neurons from
biologically different lot numbers were used, we found a significant increase in the expression of
metallothionein 1A and 1F in all samples after exposure to particulate matter as confirmed by
quantitative PCR. These metallothionein 1 proteins are responsible for neuroprotection after exposure to
environmental insult but prolonged induction can be toxic. Epidemiological studies have reported that in
utero exposure to ultrafine PM not only leads to neurodevelopmental and behavioral abnormalities, but
may also predispose the progeny to neurodegenerative disease later in life by genetic imprinting. Our
results pinpoint some of the PM-induced genetic changes that may underlie these findings.
ã 2016 Elsevier B.V. All rights reserved.
Contents lists available at ScienceDirect
NeuroToxicology1. Introduction
Emerging evidence has implicated air pollution exposure as a
risk factor for both neurodevelopmental and neurodegenerative
abnormalities (Block et al., 2012; Costa et al., 2014; Davis et al.,
2013; Genc et al., 2012). Maternal exposure to ultrafine particulate
matter (PM) can alter fetal brain development in a manner that
predisposes the progeny to neurodevelopmental disorders (Allen
et al., 2014; Hougaard et al., 2015). Numerous reports have linked
prenatal exposure to air pollution with an increased incidence of
autism spectrum disorder (ASD) among children (Kalkbrenner
et al., 2015; Raz et al., 2015; Volk et al., 2013). Correlations have
been made between air pollution exposure and several other
behavioral disorders including anxiety, depression, and schizo-
phrenia (Pedersen et al., 2004; Perera et al., 2012, 2011). Cognitive* Corresponding author at: Department of Pharmaceutical Sciences, College of
Pharmacy, Western University of Health Sciences, 309 E. Second Street, Pomona, CA
91766-1854, USA.
E-mail address: acampbell@westernu.edu (A. Campbell).
http://dx.doi.org/10.1016/j.neuro.2016.11.001
0161-813X/ã 2016 Elsevier B.V. All rights reserved.deficits and structural brain alterations have also been found in
children exposed to high levels of air pollution (Calderon-
Garciduenas et al., 2011; Freire et al., 2010). Early life exposure
may result in genetic imprinting that increases the risk of
neurodegenerative disease later in life (Lahiri et al., 2009)
including decreased cognitive function, stroke, Parkinson’s disease,
and Alzheimer’s disease (AD) (Block et al., 2012; Chen and
Schwartz, 2009; Moulton and Yang, 2012; Ritz et al., 2016). The
effects of air pollution on the aging brain may also be direct and a
recent population-based cohort study in Taiwan found a 138%
increased risk for developing AD when living in areas containing
high PM (Jung et al., 2015).
Despite our current knowledge of the adverse CNS effects of air
pollution and despite existing EPA standards in the USA, it is still
estimated that over 100 million people live in areas that exceed the
recommended air quality levels (United States. Environmental
Protection Agency, Office of Air Quality Planning and Standards and
United States, Environmental Protection Agency, Air Quality Trends
Analysis Group). Living under such circumstances is especially
prevalent in urban areas. PM is generally the air pollutant that
exceeds the recommended air quality standards (Moulton and
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droplets suspended in the air. It originates from a variety of sources
including, but not limited to, vehicle emissions and industrial by-
products (Hasheminassab et al., 2013). PM is characterized by its
size, aerodynamic properties, and chemical composition, which
can all influence its biological effects. Ultrafine particles (UFP) in
particular are not filtered out during their passage through the
nose and bronchioles but can penetrate to the alveoli. From here
they are able to enter the blood circulation where they can be
distributed throughout the body (Genc et al., 2012). Because of the
small size, it is believed that UFP are able to cross the blood brain
barrier (Block and Calderon-Garciduenas, 2009). Their large
surface area, can enhance both oxidant capacity and greater
inflammatory potential. Together with their ability to access the
CNS these properties allow ultrafine particles to contribute to the
pathogenesis of CNS diseases (Poon et al., 2004).
Although growing evidence implicated air pollution as contrib-
uting to adverse health effects on the brain, the underlying
mechanisms and sequence of events that culminate in neurotox-
icity remain poorly understood (Block et al., 2012; Lucchini et al.,
2012). In this study, we evaluated gene expression profiles in
human neurons after exposure to UFP. The UFP were collected from
a sampling site in downtown Los Angeles, which is heavily
impacted by pollution from vehicle emissions. The use of normal
primary neurons serves as a good model system for identifying
changes in gene expression in the human brain, particularly when
observing gene expression changes that may be species-specific.
We performed a whole genome wide expression analysis upon
neuronal cells derived from fetal tissue of three different samples.
Understanding how UFP affects gene expression may help identify
early genetic markers of dysregulated pathways that ultimately
contribute to CNS abnormalities (Block et al., 2012; Cooper-Knock
et al., 2012). This exploratory report may help explain the
mechanism by which exposure to UFP can contribute to the
etiology of several neurodevelopmental and neurodegenerative
diseases.
2. Materials and methods
2.1. UFP collection & characterization
Ambient ultrafine particles (UFP, diameter Dp < 0.18 mm) were
collected during January and February of 2014, on Zefluor filters
(supported PTFE, 3.0 mm pore size, Pall Life Sciences) using a High-
Volume Ultrafine Particle (HVUP) Sampler (Misra et al., 2002) at
400 L/min near downtown Los Angeles, about 120 m downwind of
the CA-110 Freeway. The particles were then extracted into an
aqueous suspension by 5 min of soaking in Milli-Q ultrapure water
(resistivity 18.2 MV), followed by vortexing (5 min) and sonication
(30 min). The dose of the PM solution was determined by
gravimetric analysis. Briefly, the filters were weighed prior to
the extraction using a microbalance (Sartorius, model LA 130-F).
After the extraction process was completed the filters were dried
and weighed again. The difference of the two gravimetric
measurements was the mass of the PM that was extracted into
the solution. Elemental content of the slurries was quantified using
a high-resolution sector field inductively coupled plasma mass
spectrometry (ICP-MS, Thermo Finnigan Element 2). Details of this
method are described in Herner et al. (Herner et al., 2006). Total
organic carbon was also quantified using a Sievers 900 organic
carbon analyzer, following the method of Stone et al. (Stone et al.,
2009). To investigate whether airborne size characteristic is
preserved after extraction in ultrapure water using vortexing
and sonication, we measured the aqueous-phase size distribution
of PM using Dynamic Light Scattering (DLS). The size distribution
of particles in the aqueous-phase by both number and surface areawere partitioned in a size range similar to the airborne ultrafine
PM, indicating that size distribution is overall well-preserved after
water extraction, and the impact of particle agglomeration is
trivial.
2.2. Primary neuron cell culture and treatment
Primary human neurons (HN, Cat. #1520) were purchased from
ScienCell Research Laboratories and maintained at 37 C in 5% CO2
in neuronal medium (NM, Cat. #1521) supplemented with 1%
neuronal growth supplement (NGS, Cat. #1562) and 1% penicillin/
streptomycin solution (P/S, Cat. #0503). Neurons were plated at a
density of 5 10^5 cells per well on 6-well cell culture plates that
had been pre-treated with 15 mg/mL poly-L-lysine (PLL, Cat.
#0413). The neurons were fully differentiated before treatments.
Cells were determined to be differentiated by distinct morpholog-
ical features that are characteristic of normal neurons we have
previously reported (Campbell et al., 2014). Neurons were treated
for 24 h with either an ultrapure aqueous solution (control) or with
20 mg/mL ultrafine particulate matter suspended in the ultrapure
aqueous solution. In our previous studies we demonstrated that
ROS and TNF-alpha levels change in primary human neurons
exposed to PM within 24 h, and thus continued to use this time
point for our current study (Campbell et al., 2014). Primary human
neurons came from 3 different fetal samples and were identified by
their lot numbers: 10866, 12732 and 13879. UFP were used for
exposures because of their unique ability to penetrate the blood-
brain-barrier (BBB) and gain access to neurons. In our previous
experiments, we had used UFP in the range of 2–20 mg/mL. In this
study, the higher dose was selected to better reflect the
concentrations used by other investigators. These are in the range
of 1–500 mg/mL (Bhavaraju et al., 2014; Campbell et al., 2014; Han
et al., 2012).
2.3. Cell viability assays
Cells were lysed and an ATP-dependent cell viability assay was
used to determine the viability of the cells after treatments with
ultrafine PM. Cell Titer Glo reagent was used according to the
manufacturers protocols (Promega, Madison, Wisconsin).
2.4. RNA collection and quantitative real-time PCR
RNA was isolated using RNeasy Mini columns (Qiagen)
according to the manufacturer’s instructions. Collected RNA was
either directly used for microarray analysis, or saved for subse-
quent confirmation of microarray results by quantitative real time
PCR (qPCR) analysis. Briefly, reverse transcription of 1 mg of total
RNA was performed with SuperScript III Reverse Transcriptase (Life
Technologies) according to the manufacturer’s protocols using
random hexamer primers (Life Technologies). Synthesized cDNA
was then used as a template for qPCR at a 1:10 dilution and
quantitative PCR analysis was performed using SYBR Green PCR
Master Mix (Applied Biosystems) according to standard protocols
on a CFX96 Touch (Bio-Rad) real-time PCR machine. Primers were
designed with Primer Express 3.0 (Table S1) using the Transcript
Cluster sequence used on the Affymetrix microarray, and then
purchased from Fisher Scientific (Pittsburgh, PA). Data was
normalized to the HMBS housekeeping gene. We previously
determined that the expression of this housekeeping gene was not
influenced by exposure to PM, and out of 14 well known
housekeeping genes tested HMBS appeared to be best suited to
use in primary neurons (data not shown). The housekeeping gene
primers came from a set of validated primers whose sequences
were proprietary (Prime PCR plate, Bio-Rad, cat# 10025217).
Where applicable, a student’s 2-tailed t-test was performed to
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2.5. Microarray analysis
Isolated total RNA was processed using the Affymetrix
GeneChip Whole Transcript Sense Target Labeling Assay according
to the manufacturer’s recommendations (Affymetrix, Inc., Santa
Clara, CA). Eluted total RNA was quantified by NanoDrop
(ThermoScientific, Wilmington, DE). Quality of the total RNA from
each sample was assessed by an RNA 6000 Nano LabChip and
evaluated on an Agilent Biolanalyzer 2100 (Agilent Technologies,
Palo Alto, CA). The Affymetrix GeneChip WT plus reagent
expression kit (Affymetrix, Inc., Santa Clara, CA) was used to
prepare RNA samples for whole transcriptome microarray analysis.
Briefly, random hexamers that were tagged with a T7 promoter
were used in first strand synthesis of cDNA followed by second
strand synthesis with the use of the T7 promoter. In vitro
transcription was then performed with the double stranded cDNA
template in order to generate many copies of antisense cRNA.15 mg
of antisense cRNA was used as a template for a second cycle cDNA
reaction, with reverse transcriptase and random primers, to
produce single stranded DNA in the sense orientation form. The
single-stranded DNA was fragmented to an average length of 70
bases and then labeled using a recombinant terminal deoxynu-
cleotidyl transferase (TdT) and an Affymetrix proprietary DNA
labeling reagent that is covalently linked to biotin. 2 mg of the
labeled, fragmented single-stranded cDNA was hybridized at 45 C
with rotation for 17 h (Affymetrix GeneChip Hybridization Oven
640) to more than 48,000 probe sets present on an Affymetrix
GeneChip 2.0ST array. Noncoding RNA (ncRNA), including long
noncoding (lncRNA) and intergenic noncoding RNA (lincRNA)
transcripts, were present in these probe sets because recent
evidence has pointed to the fact that differential expression of
these transcripts plays an important role in the origin and
progression of disease. The GeneChip arrays were washed and
then stained with streptavidin-phycoerythrin on an Affymetrix
Fluidics Station 450 (Fluidics protocol FS450_007). Arrays were
scanned using GeneChip Scanner 3000 7G and Command Console
Software v. 3.2.3 to produce CEL intensity files. The probe cell
intensity files (*.CEL) were analyzed in Affymetrix Expression
Console software v1.1.1 using the PLIER algorithm to generate
probe level summarization files (*.CHP). The settings used were
algorithm-PLIER v2.0; quantification scale-Linear; quantification
type-signal and detection p-value; background-PM-GCBG; nor-
malization method-sketch-quantile. Probe level summarization
files (*.CHP) were then analyzed with the use of Transcriptome
Analysis Console (TAC) Software from Affymetrix to determineFig. 1. Ultrafine PM characterization.
Mass fraction (mg/mg PM) of total organic carbon (TOC) and total elements and metals i
bars represent the method uncertainties.differences in expression between the 3 different samples and 2
treatment groups. Targets were selected for further analysis if they
were significantly up or down regulated with a one-way ANOVA p-
value of 0.05, and/or had a fold-change in expression of >2.0.
3. Results
3.1. PM Characterization
Fig. 1A shows the contribution of Total Organic Carbon (TOC), as
well as trace elements and metals to the overall mass of the
ultrafine particles. TOC, accounting for 43  2% of the total ultrafine
mass, consisted of a great number of primary organic compounds
(including but not limited to Polycyclic Aromatic Hydrocarbons
(PAHs), Hopanes, Steranes and Alkanes), in addition to water
soluble organic compounds originating from secondary organic
aerosol formation processes (Hasheminassab et al., 2013). Total
elements and metals, were calculated as the cumulative mass
fraction of 50 species (Table S2) and constituted 16  1% of the
ultrafine mass (Fig. 1A). Despite their relatively small contribution
to ultrafine mass, certain metals are of utmost toxicological
importance due to their potential to induce oxidative stress in cells
(Shi et al., 2003; Valavanidis et al., 2005). Fig. 1B, shows mass
fraction (ng/mg PM) of 12 metal species (including Fe, Zn, Cu, Mn,
Ni, Cr, Pb, V, As, Co, La and Cd) that were previously found to be
associated with the ultrafine-induced oxidative potential (Saffari
et al., 2013a, 2014; Verma et al., 2009). Fe is the most predominant
redox-active metal, with mass fraction of 9.5  0.08 ng/mg PM,
followed by Zn, Cu, Mn, Ni and Cr (mass fractions ranging between
0.2 and 3.5 ng/mg PM). These metals originate from a variety of
sources in the Los Angeles area, most notably vehicular emissions,
ship emissions and industrial activities (such as fuel oil combus-
tion in refineries and metal plating) (Saffari et al., 2013b). It is
important to note that the chemical composition of ultrafine
particles is strongly affected by temporal and spatial variations and
therefore the organic carbon and metal mass fractions presented
here is specific to this sample and would likely be different for
particles in other locations or collected during a different season.
3.2. Exposure to UFP alters expression of several noncoding RNAs
The entire set of 48,226 probes on the Affymetrix microarray
was analyzed to determine expression changes between the
control and the 20 mg/mL UFP treated primary human neurons
with the use of Expression Console1 and Transcriptome Analysis
Console software from Affymetrix. We previously determined that
there were no significant changes in cell viability in these cells after
UFP exposure at this dose (Fig. S1). From this microarray analysis itn the ultrafine slurry (a), and mass fraction (ng/mg PM) of selected metals (b). Error
Fig. 2. Summary of microarray results based on Affymetrix Expression Console software v1.1.1.
Summary of the number of hits per category (a) and percentage of hits per category (b) obtained from using the Transcriptome Analysis Console (TAC) software by Affymetrix.
Noncoding RNA includes miRNA, SNORDs (small nucleolar RNA), long noncoding RNA, and antisense RNA making up a total of 80% of the hits.
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particulate matter for 24 h, primary human neurons had a
significant change in the expression of 128 transcripts. This
includes a decrease in the expression of 67 transcripts and an
increase in the expression of 61 transcripts. Several of the
significant changes were in transcript cluster IDs with no
associated gene names. 102 of the 128 genes showing significant
change were transcripts for noncoding RNA. The expression of 51 of
these were decreased after exposure to UFP and 51 were increased.
These noncoding RNAs included long noncoding RNAs, microRNAs,
small nucleolar RNA (SNORDs), and antisense RNA. Based on the
Affymetrix Expression Console software v1.1.1, noncoding RNAs
made up less than 22% of the transcripts on the array, but made up
80% of our 128 hits that were identified based on differences in
expression between 3 samples and 2 treatment group (Fig. 2).
3.3. Expression of proteins upregulated upon exposure to UFP
The TAC Affymetrix software revealed 11 protein coding
transcript genes which were significantly up or down regulated
in response to UFP by 2 fold or greater and with a p-value  0.05
(Table 1). We followed up on those changes reflecting increase
gene expression by quantitative PCR analysis. OR4D11, MT1A,
OR5B3, and CFHR3 transcripts are upregulated in response to UFP
(Table 2). The samples used for our experiments came from 3
different lot numbers, and as such, the baseline gene expression
pattern from each lot number varied widely. These samples not
only had different baseline gene expression patterns in control
samples, but also had different degrees of response to particulateTable 1
Protein Coding Transcript Hits Based on Affymetrix Software.
Gene Symbol Description 
MMP13 matrix metallopeptidase 13 (collagenase 3) 
HIST1H3C histone cluster 1, H3c; histone cluster 1, H3f; histone cluste
OR1L4 olfactory receptor, family 1, subfamily L, member 4 
NXPE2 neurexophilin and PC-esterase domain family, member 2 
TAS2R40 taste receptor, type 2, member 40 
OR2F2 olfactory receptor, family 2, subfamily F, member 2 
DCAF4L1 DDB1 and CUL4 associated factor 4-like 1 
OR4D11 olfactory receptor, family 4, subfamily D, member 11 
MT1A metallothionein 1A 
OR5B3 olfactory receptor, family 5, subfamily B, member 3 
CFHR3 complement factor H-related 3 
List of protein coding transcripts found to be either significantly upregulated or significa
filtered by fold change (2.0) and ANOVA p-value (0.05). A negative value denotes dmatter as demonstrated by our principal component analysis (PCA)
(Fig. S2). Despite this variation that was present in our human
samples, the expression of MT1A was significantly increased in all
3 samples (Fig. 3). We also looked at the effects of UFP on the
expression of several other metallothionein 1 (MT1) isoforms
involved in xenobiotic metabolism (including MT1JP, MT1CP,
MT1F, MT1G, MT1X, and MT1E) in order to determine the
specificity of this MT1A induction in response to UFP. MT1A and
MT1F expression were the only isoforms that increased in all 3
donor samples treated with UFP (Fig. 3), indicating that exposure
to ultrafine PM has a significant impact on specific isoforms of
these neuroprotective genes.
4. Discussion
4.1. Non coding RNAs
Following an acute exposure to ultrafine particulate matter for
24 h, human primary neurons had a significant change in the
expression of 128 transcripts. This included 102 noncoding RNAs,
11 protein coding transcripts, and 15 undefined or novel tran-
scripts. This study is the first to report such a considerable change
in the expression of noncoding RNAs in human CNS cells after
exposure to UFP. Noncoding RNAs are transcripts that have no
apparent protein coding function (Rinn and Chang, 2012). We now
know that only 2% of the human genome is translated into protein,
yet more than 50% of the genome is transcribed into RNA (Enciu
et al., 2012). This means that most transcripts are noncoding. Cells
can use these noncoding RNAs to repress or activate geneTranscript Cluster ID Fold Change ANOVA
p-value
16743764 4.67 0.0447
r 1, H3b 17005539 3.24 0.0223
17088819 2.78 0.0464
16731515 2.27 0.0452
17052746 2.09 0.0326
17052881 2.06 0.0216
16966389 2.2 0.0196
16725097 2.22 0.0161
16819233 2.7 0.0407
16738613 3.08 0.0452
16675428 4.33 0.0004
ntly downregulated upon exposure to UFP in primary human neurons. Results are
ownregulation of the gene expression.
Table 2
Microarray Results Confirmed by qPCR.
Gene
Symbol
Fold Change
(Microarray)
Fold Change
(qPCR)
OR4D11 2.22 7.4
MT1A 2.7 1.8
OR5B3 3.08 19.5
CFHR3 4.33 2.2
Confirmation of microarray changes with an upward change in expression after
exposure to UFP in primary human neurons by qPCR.
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expression in response to environmental stimuli.
We and others have shown that exposure to ambient PM
upregulates inflammatory processes in the brain (Campbell et al.,
2005, 2009; Levesque et al., 2011; Morgan et al., 2011). Noncoding
RNAs such as miRNA and lncRNA play an important role in
regulating the magnitude of inflammatory responses (Elling et al.,
2016; O’Connell et al., 2012; O’Neill et al., 2011). Considering that
our findings are in differentiated human neurons, it is plausible
that these cells have the intrinsic capability of determining the
degree of local neuroinflammation by control of noncoding RNA
expression. This may be a mechanism of protection against
uncontrolled inflammatory processes that are known to be
neurotoxic. In fetal derived human neurons, the appropriate
modulation of the expression levels of noncoding RNA may reflect
successful protection against environmental stressors such as UFP.
The susceptibility to developmental and degenerative changes
may be associated with the capability to modulate noncoding RNA
gene expression necessary for neuronal survival. Considering that
90% of disease-associated single nucleotide polymorphisms are
located in noncoding DNA elements (Kumar et al., 2013), adds to
the plausibility of this contention.
Noncoding RNAs were initially studied extensively because the
dysregulation of expression has been shown to contribute to
carcinogenesis (Haemmerle and Gutschner, 2015). However,
recently noncoding RNA dysfunction has also been associated
with brain abnormalities. In the developing brain, antisense RNA
corresponding to the SYNGAP1 locus (SYNGAP1-AS) is differen-
tially expressed in brain regions of patients with ASD when
compared to control individuals (Velmeshev et al., 2013). In
postmortem CNS tissue from ASD patients microarray analysis
shows that over 200 lncRNAs are differentially expressed (Ziats and
Rennert, 2013). lncRNA have the ability to change the accessibility
of gene promoters by recruiting proteins to the promoter or byFig. 3. Expression of MT1A and MT1F is significantly increased in human neurons exp
Quantitative PCR analysis of human primary neurons confirms results from microarray a
samples. B. Normalized expression of MT1A and MT1F in all lot numbers. Bars represent th
the same sample treated with a water control. Expression of metallothionein isoforms MT
primary human neurons from 3 distinct lot numbers. *p-value  0.05; **p-value  0.01blocking their access to the promoter (Batista and Chang, 2013).
Few studies have looked at the effects of PM on the expression of
noncoding RNA, and none to date have looked at these effects in
the human brain. With the rapidly increasing identification of, and
functional analysis of, new noncoding RNAs, understanding of the
association between these noncoding RNAs and CNS abnormalities
will be increasingly facilitated (Guennewig and Cooper, 2014).
4.2. Changes in specific protein coding mRNAs
We also confirmed by qPCR that the expression of two
metallothioneins, MT1A and MT1F, are significantly up-regulated
upon exposure to UFP in all three of our different samples.
Although there was significant variation among gene expression
patterns in response to exposure to PM, metallothionein 1 isoforms
A and F were upregulated in all three samples derived from
different lot numbers. Since the metallothionein isoforms are such
small similar proteins, there is an absence of available assays that
are capable of accurately distinguishing between the different MT
isoforms. Thus, we were limited in our ability to determine the
effects of MT1A and MT1F at the protein level in this study.
Metallothioneins are low molecular weight neuroprotective
proteins that play a major role in metal detoxification by
sequestering metals like zinc and copper (Stankovic et al., 2007;
Stelmashook et al., 2014). They are induced in response to
environmental stressors, and provide protection in the aging
brain through zinc-mediated transcriptional regulation of genes
involved in cell growth, proliferation, and differentiation (Cherian
and Apostolova, 2000; Sharma and Ebadi, 2014). The homeostasis
of metallothioneins is crucial, as dysregulation of Zn2+ and Cu2+ in
the brain can be damaging for neurons. Metal-ion dyshomeostasis
and metallothionein dysregulation are likely to be critical elements
in neurodegenerative diseases of aging such as AD (Bonda et al.,
2011; Hozumi, 2013). In fact, mouse models of neurodegenerative
diseases which cannot express MTI/II express accelerated neuro-
degeneration (Stankovic et al., 2007). A metal-ion imbalance has
also been noted in many studies of children with autism, and it has
been suggested that this may occur because of a dysfunction in
metallothionein (MT) proteins (Bjorklund, 2013).
Since the UFP collected from the Los Angeles ambient air are
rich in metals, most notably iron, zinc, and copper, this may lead to
induction in MT1 expression followed by subsequent metal
detoxification. This is consistent with the reports of an increase
in MT1 expression in the brains of dogs living in highly polluted
regions of Mexico (Calderon-Garciduenas et al., 2003). In the CNS,osed to UFP.
nalysis. A. Normalized gene expression profile of MT1A and MT1F based on specific
e gene expression normalized to HMBS housekeeping gene and relative to cells from
1A and MT1F are significantly increased in response to ultrafine particulate matter in
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heavy metal induced oxidative stress related damage and cell
death through anti-inflammatory and antioxidant mechanisms
(Sharma et al., 2013; Stankovic et al., 2007). Even though MTs are
known to be protective when induced, their enhanced induction by
PM may also signify the toxicity of these particles. Although the
mechanism is not clearly understood, prolonged elevated MTI/
MTII expression in the brain has been consistently shown to be
correlated with the onset and progression of neurodegenerative
diseases such as Alzheimer’s disease, Parkinson’s disease, multiple
sclerosis and motor neuron disease (Manso et al., 2011; Stankovic
et al., 2007). In the case of AD, animal studies support the
hypothesis that there is an interaction between MTI/II induction
and amyloid-beta deposition (Carrasco et al., 2006). Future studies
are needed to determine whether the prolonged induction of
MT1A and MT1F isoforms by PM specifically contributes to the
progression of AD or is a secondary protective response triggered
by the underlying pathology.
Also confirmed by qPCR was the up-regulation of two olfactory
receptor genes, OR4D11 and OR5B3. These are protein coding
genes involved in the production of G-protein coupled transmem-
brane receptors which enable the detection and transmission of
olfactory stimuli. Since the initial site of impact of inhaled particles
is largely on the olfactory epithelium, these genes are likely to be
especially susceptible to modification by PM. CFHR3 (complement
factor H related 3) expression was also elevated in PM-treated cells.
The protein encoded by this gene is a secreted protein, which
belongs to the complement factor H-related protein family.
Mutations in this gene are associated with an increased risk of
atypical hemolytic-uremic syndrome. Cyclosporine induces endo-
thelial cells to release microparticles that activate the complement
system and lead to bystander injury to the kidneys and vasculature
(Renner et al., 2013). In a similar manner, modulation of the
complement pathway by airborne nanoparticles may account for
some of their toxicity. Abnormally high serum levels of the
immunoglobulins IgA and IgM, as well as the complement
component C3c have been found in adults chronically exposed
to high levels of ambient air pollution (Hadnagy et al., 1996).
The studies presented in this report were conducted in CNS cells
obtained from human fetuses. Changes in gene expression, such as
the ones observed, can persist in a quiescent state but ultimately
lead to emergence of neurological deficits. The fetal basis of adult
disease hypothesis states that many adult diseases have a
developmental origin. Lahiri and colleagues proposed the LEARn
(Latent Early-life Associated Regulation) model as a way to explain
the onset of idiopathic CNS diseases. In this model, early life
exposure to agents that act as stressors can cause epigenetic
changes. These changes induce a short-term upregulation of
disease-related genes followed by a long latency period of ‘normal’
levels of gene expression (Lahiri et al., 2009). Ultimately, the
latency period ends and the effects of abnormal gene expression
become apparent. This may take place at those various stages of
the life span that involve shifts in gene expression, such as puberty
or senescence. This can form the basis of neurodevelopmental
disease in an adolescent, or neurodegenerative disease in the
elderly. Neonatal rats that were treated with the heavy metal lead
(Pb), which has long been known to have effects on the brain and
early developmental exposures were critical in facilitating later
brain pathology (Basha et al., 2005). Similar studies conducted in
23-year old primates show elevated expression of AD-related
genes if animals were exposed to Pb as infants (Wu et al., 2008).
Collectively these studies support the LEARn model and suggest
that the pathogenesis of CNS diseases can be strongly influenced by
early life exposures.
The genetic variation that was observed in this pilot study in the
response to UFP should not be disregarded, as this difference mayindicate an individual’s susceptibility to, or protection from,
developing neurodevelopmental and/or neurodegenerative dis-
eases. Genetic changes induced by UFP may reflect an adaptive
response to the presence of specific particle constituents such as
toxic metals. Further investigation will reveal if these changes are
of significance to the pathogenesis of CNS disorders.
5. Conclusions
The effects of ultrafine particulate matter on global gene
expression in primary human neurons was examined. There were
significant changes in the expression of several noncoding RNAs in
response to exposure to UFP found in the ambient air. Future
investigations may determine whether the neurotoxicity that
results from exposure to UFP is in part due to alterations in the
expression of these noncoding regions. It has been previously
proposed that epigenetic factors could influence the ability of
environmental contaminants to cause neurotoxicity (Block et al.,
2012). Epigenetic variations may clarify why certain subpopula-
tions, such as the very young and elderly, tend to be more
susceptible to PM exposure, and may also help explain why some
people may be more predisposed to developing CNS abnormalities
after exposure to particulate matter. We also observed a significant
increase in the expression of neuroprotective metallothioneins
MT1A and MT1F. This suggests that some properties of the UFP
cause a change in the expression of metallothionein genes in the
human brain. The results described here provide insight into the
alteration of gene expression that could occur in the brain after
exposure to air pollution. A limitation of a simplified cell-culture
based study is how well it can be translated to a more biologically
relevant in vivo system. Thus, further studies are warranted to
determine if the findings can help to explain the accumulating
evidence linking outdoor air pollution with adverse effects on CNS
health, including neurodevelopmental and neurodegenerative
disorders.
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